Vasodilatory Properties of Sacubitril/Valsartan Explored in Hypertensives Aged Over 55 Years: A Meta-Analysis

ConclusionsComparison with ARBs consistently showed superiority of the antihypertensive effect of sacubitril/valsartan. Therefore, based on the preliminary evidence derived from these small trials, sacubitril/valsartan could be proposed as an elective drug for hypertension in patients aged over 55.

http://link.springer.com/10.1007/s40292-019-00313-9

Source: High Blood Pressure and Cardiovascular Prevention - March 31, 2019 Category: Cardiology Source Type: research